Abstract

149 Furoxans (derivatives of 1,2,5 oxadiazole N oxide) are heterocyclic thermally stable compounds. Furoxans can slowly produce NO for a long time and do not cause devel opment of nitrate tolerance [1]. In the design of hybrid pharmaceuticals, they are often introduced as an NO producing fragment into the molecule of a known prepa ration to impart it with, for example, cGMP dependent vasodilation or antiaggregatory properties [1–3]. One of the recent directions in medicinal chemis try is the design of hybrid multifunctional pharmaceu ticals that combine two or more pharmacophores in one molecule. The wide spectrum of pharmacological activity of these pharmaceuticals, the ability of drug to interact with several targets, is matched against selectivity. Amino acids are often used as an addi tional pharmacophore [4]. Amino acids can behave as both independent pharmacophores and linkers for the attachment of an additional pharmacologically active fragment due to the presence of a free carboxyl group.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.